The two sites should not be treated with the same CO₂ laser strategy. For a dense, localized auricular keloid, the cited approach is focal full vaporization under local anesthesia, using approximately 4–6 W continuous emission with 0.2–1.5 W superpulsed emission at 5–10 Hz. For a broad or tension-prone thoracic post-surgical hypertrophic scar, use fractional ablation—approximately 13 W superpulsed, 1.5 ms pulse duration, and 600 µm point-to-point pitch—to preserve tissue bridges and support re-epithelialization.
Auricular keloids generally require volumetric reduction, whereas thoracic scars generally require controlled fractional remodeling. These figures are protocol-level starting points, not universal prescriptions: spot size, pulse structure, scanner geometry, tissue thickness, skin type, and the specific laser platform must be verified before treatment.
Why the anatomical site changes the settings
Auricular keloids are dense and volumetric
Auricular keloids commonly form after piercing, otoplasty, or other local trauma. Their fibrous tissue is often compact and raised, so superficial fractional treatment may not adequately reduce the mass.
The cited strategy is therefore layer-by-layer full vaporization of the excess tissue, with careful contouring to avoid removing normal auricular tissue.
Thoracic scars are broader and tension-prone
The chest is exposed to substantial mechanical tension and has a greater tendency toward hypertrophic scarring and secondary keloid formation. Excessive full-field vaporization can create a large open wound and increase healing risk.
A fractional CO₂ pattern creates microscopic treatment columns while leaving intervening tissue bridges intact. Those bridges help support faster epithelial repair and limit the effective wound burden.
Parameter framework for an auricular keloid
Emission mode and power
For the cited auricular protocol, configure the system for 4–6 W continuous emission, combined with 0.2–1.5 W superpulsed emission at 5–10 Hz.
The exact relationship between the continuous and superpulsed components depends on the laser’s control architecture. Do not assume that wattage values from one manufacturer map directly to another system.
Treatment objective
The objective is controlled volumetric vaporization, not simply surface polishing. Reduce the fibrous mass progressively and reassess the contour between tissue layers.
Avoid unnecessarily aggressive penetration into thin areas of the helix, lobule, or cartilage-adjacent tissue. The ear has limited soft-tissue reserve, and thermal or mechanical injury can compromise contour and healing.
Procedural conditions
The cited approach uses local anesthesia. Adequate immobilization, clear visualization, plume evacuation, and appropriate ocular protection are essential during vaporization.
Because ablative CO₂ treatment produces surgical plume, a dedicated smoke-evacuation system should be used rather than relying on general room ventilation.
Parameter framework for a thoracic post-surgical scar
Fractional rather than full-field delivery
For a thoracic scar with hypertrophic or keloidal characteristics, use fractional CO₂ delivery to preserve untreated tissue bridges. The cited settings are:
- 13 W superpulsed power
- 1.5 ms ablative-thermal pulse duration
- 600 µm point-to-point pitch
These settings should be confirmed against the device’s actual pulse-energy output, spot diameter, dwell time, and stacking behavior.
Treatment objective
The aim is controlled microcolumn formation and dermal remodeling, rather than complete excision or vaporization of the scar. Fractional delivery can also create channels that may support subsequent topical or intralesional treatment when clinically appropriate.
The number of passes and stacking should be limited to what is required for the intended endpoint. Increasing energy or repeating passes without reassessment raises the risk of excessive thermal injury, prolonged erythema, delayed healing, and pigmentary change.
Confirm the scar phenotype first
“Post-surgical scar” is not a sufficient diagnosis for selecting parameters. A flat mature scar, hypertrophic scar, and true keloid have different biological behavior and may require different treatment plans.
Assess elevation, firmness, activity, symptoms, vascularity, extension beyond the original incision, and the presence of ongoing tension or inflammation before choosing the treatment depth.
How to compare the two approaches
Tissue removal versus tissue remodeling
The auricular approach is primarily debulking by vaporization. It is suited to a discrete mass where reducing scar volume is the immediate goal.
The thoracic approach is primarily fractional remodeling. It is suited to a wider scar where preserving healing capacity and minimizing wound tension are central concerns.
Local anatomy matters as much as wattage
A wattage value alone does not define treatment intensity. Delivered fluence and tissue effect also depend on pulse duration, spot size, beam profile, scanner pitch, dwell time, stack count, and the number of passes.
Consequently, the same nominal power can produce substantially different tissue effects on different systems.
Understanding the trade-offs
Full vaporization can be more effective but creates more wound burden
Full ablation may reduce a bulky auricular keloid efficiently, but it removes the protective tissue layer across the treated area. This can increase postoperative exudate, delayed healing, infection risk, and contour irregularity if treatment is too deep.
It should be reserved for appropriately selected lesions and performed by clinicians experienced with ablative laser surgery and keloid management.
Fractional treatment heals more conservatively but may require multiple sessions
Fractional treatment preserves tissue bridges and generally limits the continuous open wound. However, a single session may not adequately flatten a thick keloidal or hypertrophic scar.
The supplementary protocol describes two to three sessions spaced approximately two months apart for vascularized hypertrophic or keloid scars, but the interval should be based on complete healing and clinical response rather than a fixed schedule alone.
Vascular laser pairing is not automatically required
The references describe pairing CO₂ treatment with an intraoperative or sequential 595 nm vascular laser to address vascularity, hemostasis, and angiogenesis. This may be considered when the scar is clinically vascular or erythematous, but it is not a substitute for correct scar diagnosis or mechanical-tension control.
If used, the vascular-laser parameters must be selected independently for the device, skin type, vascular target, and cooling method. Do not transfer the supplementary example of 7 J/cm², 12 mm spot size, and 0.5 ms pulse duration without platform-specific validation.
Do not extrapolate parameters from unrelated indications
Settings used for atrophic acne scars, benign lesions, mucosal lesions, or periocular treatment should not be transferred to auricular keloids or thoracic scars. Those applications differ in tissue thickness, target depth, thermal tolerance, and clinical endpoint.
How to apply this safely
Validate the platform before treatment
Before using the cited values, confirm:
- Whether the displayed wattage represents average power, peak power, or another manufacturer-specific quantity.
- The actual pulse duration and energy per microbeam.
- Spot size, scanner pattern, pitch, dwell time, and stack behavior.
- Whether continuous and superpulsed modes can be combined as described.
- The manufacturer’s tissue-effect and safety limits.
A controlled test on an appropriate tissue model or a small treatment area is preferable to assuming equivalence between devices.
Define the endpoint during treatment
For auricular treatment, use progressive layer removal with frequent inspection of contour and residual fibrous tissue. For thoracic fractional treatment, evaluate the intended microcolumn endpoint while avoiding excessive overlap or stacking.
The endpoint should be determined by the scar’s response and anatomy, not by wattage alone.
Address recurrence risk separately
Laser treatment does not eliminate the biological tendency toward keloid recurrence. Management may require a broader plan that considers excision strategy, pressure therapy, corticosteroid or other adjunctive treatment, vascularity, wound care, and tension reduction.
Any adjunct should be selected according to the scar phenotype and the practitioner’s established protocol.
Making the Right Choice for Your Goal
Use these recommendations as a framework for device-specific planning, not as a replacement for clinical examination, informed consent, and supervised laser training.
- If your primary focus is reducing a discrete auricular keloid mass: Use a carefully controlled full-vaporization strategy, with the cited 4–6 W continuous and 0.2–1.5 W superpulsed at 5–10 Hz range treated only as a platform-validated starting framework.
- If your primary focus is remodeling a broad thoracic hypertrophic scar: Prefer fractional CO₂ delivery using the cited 13 W, 1.5 ms, and 600 µm pitch framework while preserving tissue bridges and limiting stacking.
- If your primary focus is minimizing recurrence and complications: Confirm the scar diagnosis, control mechanical tension, select adjunctive therapy when indicated, and adjust treatment to the actual device output rather than relying on nominal wattage.
The safest parameter is the one that matches the scar’s biology, the anatomy, and the verified energy delivery of the specific laser system.
Summary Table:
| Site | Strategy | Power Settings | Mode & Pulse | Key Objective |
|---|---|---|---|---|
| Auricular Keloid | Full vaporization | 4–6 W continuous + 0.2–1.5 W superpulsed at 5–10 Hz | Continuous + superpulsed | Volumetric reduction with layer-by-layer ablation |
| Thoracic Scar | Fractional ablation | 13 W superpulsed | 1.5 ms pulse duration, 600 µm pitch | Controlled remodeling with preserved tissue bridges |
| General Consideration | Validate device output | Verify power ratings, spot size, and scanner settings | Confirm pulse energy and thermal effects | Match parameters to scar biology and anatomy |
Looking for a CO2 laser system that allows precise parameter control for diverse scar types? BELIS offers advanced fractional and ablative lasers designed for professional clinics. Contact us today to find the ideal solution for your practice and elevate your aesthetic treatments.
Related Products
- Fractional CO2 Laser Machine for Skin Treatment
- Fractional CO2 Laser Machine for Skin Treatment
- Cryolipolysis Fat Freezing Cavitation Lipo Laser Machine
- Cryolipolysis Fat Freezing Machine and Ultrasonic Cavitation Device
- Cryolipolysis Fat Freezing Machine with Cavitation and Laser Lipolysis
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- What parameters and treatment intervals are advised when applying fractional CO2 laser technology to delicate periorbital skin laxity? Discover safe protocols for eyelid rejuvenation.
- What is the primary function of a high-precision fractional CO2 laser system for GSM? Restore Vaginal Health Naturally
- Why do fractional CO2 laser parameters need to be differentiated? Master Keloid vs. Hypertrophic Scar Treatment
- How should laser power output be adjusted based on tissue vaporization? Mastery of Fractional CO2 Precision
